These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33603270)

  • 21. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early versus late onset interstitial lung disease in rheumatoid arthritis: An observational study of risk factors and mortality in Ontario, Canada.
    Fidler L; Widdifield J; Fisher J; Shapera S; Gershon AS
    Respirology; 2024 Mar; 29(3):243-251. PubMed ID: 38092528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineutrophil cytoplasmic antibody is an independent risk factor in rheumatoid arthritis-associated interstitial lung disease.
    Xu H; Wu Z; Zhao Y; Hu C; Li P; Deng C; Li L; Bai Y; Song N; Luo J; Feng F; He C; Li Y; Zhang S
    Clin Chim Acta; 2024 Jul; 561():119845. PubMed ID: 38969087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis.
    Rocha-Muñoz AD; Ponce-Guarneros M; Gamez-Nava JI; Olivas-Flores EM; Mejía M; Juárez-Contreras P; Martínez-García EA; Corona-Sánchez EG; Rodríguez-Hernández TM; Vázquez-del Mercado M; Salazar-Páramo M; Nava-Zavala AH; Cardona-Muñoz EG; Celis A; González-Lopez L
    J Immunol Res; 2015; 2015():151626. PubMed ID: 26090479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Kim D; Cho SK; Choi CB; Choe JY; Chung WT; Hong SJ; Jun JB; Jung YO; Kim TH; Kim TJ; Lee HS; Lee JH; Lee J; Lee SS; Yoo DH; Yoon BY; Song JW; Bae SC; Sung YK
    Rheumatol Int; 2017 Oct; 37(10):1735-1745. PubMed ID: 28748423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.
    Fernández-Díaz C; Atienza-Mateo B; Castañeda S; Melero-Gonzalez RB; Ortiz-SanJuan F; Loricera J; Casafont-Solé I; Rodríguez-García S; Aguilera-Cros C; Villa-Blanco I; Raya-Alvarez E; Ojeda-García C; Bonilla G; López-Robles A; Arboleya L; Narváez J; Cervantes E; Maiz O; Alvarez-Rivas MN; Cabezas I; Salgado E; Hidalgo-Calleja C; Fernández S; Fernández JC; Ferraz-Amaro I; González-Gay MA; Blanco R;
    Rheumatology (Oxford); 2021 Dec; 61(1):299-308. PubMed ID: 33779697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
    Ota M; Iwasaki Y; Harada H; Sasaki O; Nagafuchi Y; Nakachi S; Sumitomo S; Shoda H; Tohma S; Fujio K; Yamamoto K
    Mod Rheumatol; 2017 Jan; 27(1):22-28. PubMed ID: 27142966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.
    Raimundo K; Solomon JJ; Olson AL; Kong AM; Cole AL; Fischer A; Swigris JJ
    J Rheumatol; 2019 Apr; 46(4):360-369. PubMed ID: 30442831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial Lung Disease and its Associations in Rheumatoid Arthritis: Data from a District General Hospital in Sri Lanka.
    Wickrematilake G
    Clin Med Insights Arthritis Musculoskelet Disord; 2021; 14():11795441211028747. PubMed ID: 34262385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
    Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
    Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
    Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA.
    Gizinski AM; Mascolo M; Loucks JL; Kervitsky A; Meehan RT; Brown KK; Holers VM; Deane KD
    Clin Rheumatol; 2009 May; 28(5):611-3. PubMed ID: 19252818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.
    Del Angel-Pablo AD; Buendía-Roldán I; Mejía M; Pérez-Rubio G; Nava-Quiroz KJ; Rojas-Serrano J; Falfán-Valencia R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
    Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y
    Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial lung disease throughout the rheumatoid arthritis disease course.
    McDermott GC; Doyle TJ; Sparks JA
    Curr Opin Rheumatol; 2021 May; 33(3):284-291. PubMed ID: 33625044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.